+39 02 610346.1 - info@newron.com

Latest press releases

  • 21Feb
    Newron Supports Global Rare Disease Day® 2017 and Rett Syndrome Studies


  • 10Jan
    Seqirus and Zambon enter into a partnership for Parkinson’s disease product in Australia and New Zealand

  • 3Jan
    Evenamide met study objectives of good tolerability, safety, and preliminary evidence of efficacy as an add-on therapy for the treatment of schizophrenia- unique MoA


  • 23Dec
    Change in Newron’s Senior Management Team


  • 21Oct
    US FDA considers Newron’s re-submitted NDA for Xadago® to be a complete, class 2 response to Complete Response Letter PDUFA date March 21, 2017


  • 7Oct
    Newron raises CHF26.1 Mio. in a private placement of new shares


View All

Newron share price


  • 20Sep
    Investora 2017

    Sept. 20-21, 2017 - Zurich, CH

  • 6Jun
    Jefferies 2017 Global Healthcare Conference

    June 6-9, 2017 at the Grand Hyatt in New York City

  • 22May
    Bio€quity Europe 2017

    May 22-23 - Paris, France

View Event Calendar